"T-Lymphocyte Subsets" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A classification of T-lymphocytes, especially into helper/inducer, suppressor/effector, and cytotoxic subsets, based on structurally or functionally different populations of cells.
- T-Lymphocyte Subsets
- Subset, T-Lymphocyte
- Subsets, T-Lymphocyte
- T Lymphocyte Subsets
- T-Lymphocyte Subset
- T-Cell Subsets
- Subset, T-Cell
- Subsets, T-Cell
- T Cell Subsets
- T-Cell Subset
Below are MeSH descriptors whose meaning is more general than "T-Lymphocyte Subsets".
Below are MeSH descriptors whose meaning is more specific than "T-Lymphocyte Subsets".
This graph shows the total number of publications written about "T-Lymphocyte Subsets" by people in this website by year, and whether "T-Lymphocyte Subsets" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "T-Lymphocyte Subsets" by people in Profiles.
Memory Precursors and Short-Lived Effector T cell Subsets Have Different Sensitivities to TGF?. Int J Mol Sci. 2023 Feb 15; 24(4).
Longitudinal analysis reveals age-related changes in the T cell receptor repertoire of human T cell subsets. J Clin Invest. 2022 09 01; 132(17).
CD11c+CD163+ Cells and Signal Transducer and Activator of Transcription 3 (STAT3) Expression Are Common in Melanoma Leptomeningeal Disease. Front Immunol. 2021; 12:745893.
Lymph Node-Targeted Synthetically Glycosylated Antigen Leads to Antigen-Specific Immunological Tolerance. Front Immunol. 2021; 12:714842.
A multilayered immune system through the lens of unconventional T cells. Nature. 2021 07; 595(7868):501-510.
IDO1 Expression in Ovarian Cancer Induces PD-1 in T Cells via Aryl Hydrocarbon Receptor Activation. Front Immunol. 2021; 12:678999.
Anti-CD20 therapy corrects a CD8 regulatory T cell deficit in multiple sclerosis. Mult Scler. 2021 12; 27(14):2170-2179.
An Immunosuppressive Effect of Melanoma-derived Exosomes on NY-ESO-1 Antigen-specific Human CD8+ T Cells is Dependent on IL-10 and Independent of BRAFV600E Mutation in Melanoma Cell Lines. Immunol Invest. 2020 Oct; 49(7):744-757.
Pro-lymphangiogenic VEGFR-3 signaling modulates memory T cell responses in allergic airway inflammation. Mucosal Immunol. 2021 01; 14(1):144-151.
Loss of BIM in T cells results in BCL-2 family BH3-member compensation but incomplete cell death sensitivity normalization. Apoptosis. 2020 04; 25(3-4):247-260.